Highlights
NASDAQ: ADXS       Advaxis Inc
Last Price Today's Change   Day's Range   Trading Volume
0.399   +0.019 (5.00%)  0.368 - 0.415  7,395,800

Overview

 
Avg Volume (4 weeks):3,390,340
4 Weeks Range:0.263 - 0.415
4 Weeks Price Volatility (%):
89.47%
52 Weeks Range:0.18 - 10.80
52 Weeks Price Volatility (%):
2.06%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company’s immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers